Dr. Boger holds a bachelor of arts in Chemistry and Philosophy from Wesleyan University (Connecticut) and a master's and doctorate degrees in Chemistry from Harvard University.  His postdoctoral research in molecular recognition was performed in the laboratories of the Nobel-prize winning chemist, Jean-Marie Lehn in Strasbourg, France.  He is the author of over 50 scientific publications, holds 31 issued U.S. patents in pharmaceutical discovery and development, and has lectured widely in the United States, in Europe and in Asia on various aspects of drug discovery and development.  He was named one of forty “Technology Pioneers” worldwide for the 2003 World Economic Forum in Davos, Switzerland.

Dr. Boger is Chairman of BIO (the biopharmaceutical industry trade association), a founding Director and Secretary of the New England Healthcare Institute (a non-profit, healthcare-policy research organization based in Cambridge. MA), Chairman of the Massachusetts High Technology Council, a founding Director and Co-Chairman of the Progressive Business Leaders Network (a non-profit, non-partisan business organization), Vice-Chair of the Board of Fellows of the Harvard Medical School and Chair-Elect of the Board of the Celebrity Series (Boston’s premier performing arts series).  He serves on several additional Boards including Wesleyan University (Middletown, CT), the Science Advisory Council of WGBH (public broadcasting’s leading station, Boston), the Massachusetts Workforce Investment Board, the Massachusetts Life Sciences Center, the Dean’s Advisory Group of the Harvard School of Engineering and Applied Sciences, the Harvard College Overseers’ Committee to Visit the Medical School & School of Dental Medicine and the MIT Corporation Visiting Committee to the Department of Biology.